Articles

O.2 Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation

BJH - volume 5, issue Abstract Book BHS, january 2014

M. Binsfeld , Y. Beguin MD, PhD, L. Belle , E. Otjacques , M. Hannon , A. Briquet PhD, P. Drion , B. Bogen , F. Baron MD, PhD, J. Caers MD, PhD

Read more

P1.10 Immunomodulatory effects of Rapamycin in xenogeneic GVHD

BJH - volume 5, issue Abstract Book BHS, january 2014

G. Ehx , M. Hannon , S. Dubois , A. Halleux , L. Belle , P. Drion , Y. Beguin MD, PhD, S. Humblet-Baron , F. Baron MD, PhD

Read more

O.4 Combination of regulatory T cells injection with rapamycin for treatment of chronic Graft-versus-Host disease

BJH - 2013, issue BHS Abstractbook, january 2013

L. Belle , M. Binsfeld , M. Hannon , J. Caers MD, PhD, A. Briquet PhD, M. Menten , Y. Beguin MD, PhD, S. Humblet , F. Baron MD, PhD

Read more

O.6 Infusion of CliniMACS® (Miltenyi Biotec) enriched regulatory T-cells delays experimental xenogeneic graft-versus-host disease

BJH - 2013, issue BHS Abstractbook, january 2013

M. Hannon , C. Lechanteur PhD, J. Somja MD, S. Lucas , L. Belle , F. Bruck , E. Baudoux MD, Y. Beguin MD, PhD, S. Humblet-Baron , F. Baron MD, PhD

Read more

P.67 Comparison of immune reconstitution after hematopoietic stem cell transplantation with FLU-TBI vs. TLI-ATG conditioning

BJH - 2013, issue BHS Abstractbook, january 2013

M. Hannon , S. Humblet-Baron , C. Graux MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, K. Theunissen , C. Daulne , E. Willems MD, PhD, L. Belle , M. Binsfeld , A. Gothot MD, PhD, Y. Beguin MD, PhD, F. Baron MD, PhD

Read more

P.73 The immunomodulating peptide thymosin alpha 1 has no effects on multiple myeloma evolution and on immune reconstitution

BJH - 2013, issue BHS Abstractbook, january 2013

M. Binsfeld , E. Otjacques , M. Hannon , S. Dubois , Y. Beguin MD, PhD, F. Baron MD, PhD, J. Caers MD, PhD

Read more